Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Czibere

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bone Marrow Transplantation|March 25, 2009
Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCTG Kobbe, I Bruns, R Fenk, et al.
Bone Marrow Transplantation|May 12, 2009
Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemiaF Zohren, A Czibere, I Bruns, et al.
Leukemia Research|June 25, 2008
Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemiaN N Safaian, A Czibere, I Bruns, et al.
Bone Marrow Transplantation|July 28, 2010
Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseasesF Zohren, T Schroeder, A Czibere, et al.
European Journal of Medical Research|February 18, 2010
Bendamustine in patients with relapsed or refractory multiple myelomaM Michael, I Bruns, E Bölke, et al.
Bone Marrow Transplantation|October 13, 2009
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysisA Czibere, I Bruns, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myelomaG Kobbe, I Bruns, T Schroeder, et al.
Leukemia|January 15, 2013
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantationT Schroeder, A Czibere, U Platzbecker, et al.
Leukemia|January 23, 2009
The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescenceI Bruns, A Czibere, J C Fischer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2020
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trialJ K Litton, S A Hurvitz, L A Mina, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bone Marrow Transplantation|March 25, 2009
Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCTG Kobbe, I Bruns, R Fenk, et al.
Bone Marrow Transplantation|May 12, 2009
Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemiaF Zohren, A Czibere, I Bruns, et al.
Leukemia Research|June 25, 2008
Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemiaN N Safaian, A Czibere, I Bruns, et al.
Bone Marrow Transplantation|July 28, 2010
Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseasesF Zohren, T Schroeder, A Czibere, et al.
European Journal of Medical Research|February 18, 2010
Bendamustine in patients with relapsed or refractory multiple myelomaM Michael, I Bruns, E Bölke, et al.
Bone Marrow Transplantation|October 13, 2009
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysisA Czibere, I Bruns, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myelomaG Kobbe, I Bruns, T Schroeder, et al.
Leukemia|January 15, 2013
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantationT Schroeder, A Czibere, U Platzbecker, et al.
Leukemia|January 23, 2009
The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescenceI Bruns, A Czibere, J C Fischer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2020
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trialJ K Litton, S A Hurvitz, L A Mina, et al.
Pageof 2